Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Acknowledgments
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Erratum Free access | 10.1172/JCI9243E1

Lethal host-versus-graft disease and hypereosinophilia in the absence of MHC I-T-cell interactions

Jérôme D. Coudert, Gilles Foucras, Cécile Demur, Christiane Coureau, Catherine Mazerolles, Georges Delsol, Philippe Druet, and Jean-Charles Guéry

Find articles by Coudert, J. in: PubMed | Google Scholar

Find articles by Foucras, G. in: PubMed | Google Scholar

Find articles by Demur, C. in: PubMed | Google Scholar

Find articles by Coureau, C. in: PubMed | Google Scholar

Find articles by Mazerolles, C. in: PubMed | Google Scholar

Find articles by Delsol, G. in: PubMed | Google Scholar

Find articles by Druet, P. in: PubMed | Google Scholar

Find articles by Guéry, J. in: PubMed | Google Scholar

Published July 1, 2000 - More info

Published in Volume 106, Issue 1 on July 1, 2000
J Clin Invest. 2000;106(1):18–18. https://doi.org/10.1172/JCI9243E1.
© 2000 The American Society for Clinical Investigation
Published July 1, 2000 - Version history
View PDF

Related article:

Lethal host-versus-graft disease and hypereosinophilia in the absence of MHC I–T-cell interactions
Jérôme D. Coudert, … , Philippe Druet, Jean-Charles Guéry
Jérôme D. Coudert, … , Philippe Druet, Jean-Charles Guéry
Article

Lethal host-versus-graft disease and hypereosinophilia in the absence of MHC I–T-cell interactions

  • Text
  • PDF
Abstract

Neonatal injection of semiallogeneic spleen cells in BALB/c mice induces a self-limited state of chimerism that promotes the differentiation of donor-specific CD4 T cells toward the Th2 phenotype. Here we show that injection of spleen cells from β2-microglobulin–deficient (BALB/c × C57BL/6) F1 mice into BALB/c newborns with a disrupted β2-microglobulin (β2m) gene results in a lethal lymphoproliferative disorder associated with uncontrolled Th2 response, long-term persistence of donor B cells, and sustained blood eosinophilia. Autoimmune manifestations are also enhanced and characterized by a severe autoantibody-mediated glomerulonephritis. Histological examination of the spleen shows a hyperplasia of periarteriolar lymphoid sheaths, with accumulation of eosinophils and basophils, and variable degree of fibrosis. Perivascular lymphoid infiltrates with eosinophils are also found in the lung and are correlated with disease severity. Such abnormalities are almost absent using β2m-sufficient mice. These data demonstrate that induction of lymphoid chimerism in the absence of MHC class I–T-cell interactions results in a lethal form of host-versus-graft disease that represents a unique model of Th2-dependent chronic inflammatory disease associated with an hypereosinophilic syndrome in mice.

Authors

Jérôme D. Coudert, Gilles Foucras, Cécile Demur, Christiane Coureau, Catherine Mazerolles, Georges Delsol, Philippe Druet, Jean-Charles Guéry

×

J. Clin. Invest.105:1125–1132 (2000)

The authors wish to apologize for the oversight in the Acknowledgment section of their recently published paper. The correct section appears below.

Acknowledgments

We thank M. Calise, S. Pilipenko, and M. Marche for their skillful technical assistance. This work was supported by Institut National de la Santé et de la Recherche Médicale (INSERM), and grants from Conseil Général de Région Midi-Pyrénées, Etablissement Français des Greffes, and Université Paul Sabatier and Association pour la Recherche contre le Cancer. G. Foucras is on a leave of absence from Ecole Nationale Vétérinaire de Toulouse, France. J. Coudert is supported by the Ministère de l’Education Nationale, de la Recherche et de la Technologie. We thank D. Abramowicz for his helpful comments on the manuscript.

Version history
  • Version 1 (July 1, 2000): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Acknowledgments
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts